Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Preferred Dividend Payments: 2011-2013

  • Cytokinetics' Preferred Dividend Payments was N/A to $4.2 million in Q3 2013 from the same period last year, while for Sep 2013 it was $12.5 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2012, which is 54.25% down from last year.
  • Cytokinetics' Preferred Dividend Payments amounted to $4.2 million in Q3 2013, which was down 0.00% from $4.2 million recorded in Q2 2013.
  • Cytokinetics' 5-year Preferred Dividend Payments high stood at $4.2 million for Q2 2013, and its period low was $1.3 million during Q2 2012.
  • Over the past 3 years, Cytokinetics' median Preferred Dividend Payments value was $2.9 million (recorded in 2012), while the average stood at $3.1 million.
  • Data for Cytokinetics' Preferred Dividend Payments shows a peak YoY surged of 218.59% (in 2013) over the last 5 years.
  • Over the past 3 years, Cytokinetics' Preferred Dividend Payments (Quarterly) stood at $2.9 million in 2011, then reached $1.3 million in 2012, then spiked by 218.59% to $4.2 million in 2013.
  • Its Preferred Dividend Payments was $4.2 million in Q3 2013, compared to $4.2 million in Q2 2013 and $1.3 million in Q2 2012.